PL3083648T3 - Sposób farmaceutyczny i półprodukty - Google Patents
Sposób farmaceutyczny i półproduktyInfo
- Publication number
- PL3083648T3 PL3083648T3 PL14828102T PL14828102T PL3083648T3 PL 3083648 T3 PL3083648 T3 PL 3083648T3 PL 14828102 T PL14828102 T PL 14828102T PL 14828102 T PL14828102 T PL 14828102T PL 3083648 T3 PL3083648 T3 PL 3083648T3
- Authority
- PL
- Poland
- Prior art keywords
- intermediates
- pharmaceutical method
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919671P | 2013-12-20 | 2013-12-20 | |
| PCT/US2014/071613 WO2015095765A1 (en) | 2013-12-20 | 2014-12-19 | Pharmaceutical process and intermediates |
| EP14828102.5A EP3083648B1 (en) | 2013-12-20 | 2014-12-19 | Pharmaceutical process and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3083648T3 true PL3083648T3 (pl) | 2019-05-31 |
Family
ID=52358996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14828102T PL3083648T3 (pl) | 2013-12-20 | 2014-12-19 | Sposób farmaceutyczny i półprodukty |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9388203B2 (pl) |
| EP (1) | EP3083648B1 (pl) |
| JP (1) | JP6522005B2 (pl) |
| CN (1) | CN105849115B (pl) |
| CA (2) | CA3186267C (pl) |
| CY (1) | CY1121313T1 (pl) |
| DK (1) | DK3083648T3 (pl) |
| ES (1) | ES2701088T3 (pl) |
| HR (1) | HRP20181933T1 (pl) |
| HU (1) | HUE042204T2 (pl) |
| LT (1) | LT3083648T (pl) |
| PL (1) | PL3083648T3 (pl) |
| PT (1) | PT3083648T (pl) |
| RS (1) | RS58084B1 (pl) |
| SI (1) | SI3083648T1 (pl) |
| SM (1) | SMT201800644T1 (pl) |
| WO (1) | WO2015095765A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109912622A (zh) * | 2019-03-20 | 2019-06-21 | 中国药科大学 | 一种福他替尼关键中间体的制备方法及其中间体和利用中间体制备福他替尼的方法 |
| CN118702735B (zh) * | 2024-07-15 | 2025-12-30 | 河北常山生化药业股份有限公司 | 福坦替尼杂质及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0413018B8 (pt) | 2003-07-30 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, e, uso de um composto |
| JP4801096B2 (ja) * | 2005-01-19 | 2011-10-26 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ２，４−ピリミジンジアミン化合物のプロドラッグおよびそれらの使用 |
| WO2008064274A1 (en) * | 2006-11-21 | 2008-05-29 | Rigel Pharmaceuticals, Inc. | Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| UA108077C2 (xx) * | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну | |
| US8389515B2 (en) * | 2009-11-20 | 2013-03-05 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and prodrugs and their uses |
-
2014
- 2014-12-19 CA CA3186267A patent/CA3186267C/en active Active
- 2014-12-19 LT LTEP14828102.5T patent/LT3083648T/lt unknown
- 2014-12-19 HU HUE14828102A patent/HUE042204T2/hu unknown
- 2014-12-19 HR HRP20181933TT patent/HRP20181933T1/hr unknown
- 2014-12-19 JP JP2016560869A patent/JP6522005B2/ja active Active
- 2014-12-19 US US14/576,544 patent/US9388203B2/en active Active
- 2014-12-19 EP EP14828102.5A patent/EP3083648B1/en active Active
- 2014-12-19 CN CN201480069979.6A patent/CN105849115B/zh active Active
- 2014-12-19 ES ES14828102T patent/ES2701088T3/es active Active
- 2014-12-19 PT PT14828102T patent/PT3083648T/pt unknown
- 2014-12-19 CA CA2934535A patent/CA2934535C/en active Active
- 2014-12-19 PL PL14828102T patent/PL3083648T3/pl unknown
- 2014-12-19 SI SI201430992T patent/SI3083648T1/sl unknown
- 2014-12-19 WO PCT/US2014/071613 patent/WO2015095765A1/en not_active Ceased
- 2014-12-19 SM SM20180644T patent/SMT201800644T1/it unknown
- 2014-12-19 DK DK14828102.5T patent/DK3083648T3/en active
- 2014-12-19 RS RS20181453A patent/RS58084B1/sr unknown
-
2016
- 2016-06-10 US US15/178,967 patent/US9695204B2/en active Active
-
2018
- 2018-12-04 CY CY20181101287T patent/CY1121313T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3083648T (lt) | 2019-01-25 |
| CN105849115A (zh) | 2016-08-10 |
| CA3186267A1 (en) | 2015-06-25 |
| US9695204B2 (en) | 2017-07-04 |
| PT3083648T (pt) | 2018-12-14 |
| CY1121313T1 (el) | 2020-05-29 |
| US20160355531A1 (en) | 2016-12-08 |
| CA3186267C (en) | 2025-09-09 |
| CA2934535A1 (en) | 2015-06-25 |
| SMT201800644T1 (it) | 2019-01-11 |
| EP3083648B1 (en) | 2018-09-12 |
| JP6522005B2 (ja) | 2019-05-29 |
| WO2015095765A1 (en) | 2015-06-25 |
| HUE042204T2 (hu) | 2019-06-28 |
| CN105849115B (zh) | 2019-06-11 |
| JP2017503018A (ja) | 2017-01-26 |
| EP3083648A1 (en) | 2016-10-26 |
| CA2934535C (en) | 2023-03-28 |
| US9388203B2 (en) | 2016-07-12 |
| US20150175639A1 (en) | 2015-06-25 |
| HRP20181933T1 (hr) | 2019-01-11 |
| SI3083648T1 (sl) | 2019-02-28 |
| ES2701088T3 (es) | 2019-02-20 |
| DK3083648T3 (en) | 2019-01-07 |
| RS58084B1 (sr) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3804863T5 (pl) | Sposób aplikacji i system aplikacji | |
| IL246002A0 (en) | Novel methods | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK4056212T3 (da) | Autoinjektor | |
| DK2992104T3 (da) | Fremgangsmåde til ekspression | |
| PL2997284T3 (pl) | Sposób eksploatacji układu napędowego oraz układ napędowy | |
| DK3041857T3 (da) | Protein a-kromatografi | |
| LT3038654T (lt) | Naujas panaudojimas | |
| BR112016011147A2 (pt) | autoinjetor | |
| IL243728A0 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| DK2943561T3 (da) | Fotobioreaktor | |
| BR112015021083A2 (pt) | método | |
| BR112016009916A2 (pt) | Aparelho de injetor e método | |
| DK3079655T3 (da) | Inhalerbare lægemidler | |
| BR112015029076A2 (pt) | método | |
| BR112016000304A2 (pt) | Sistema e método | |
| LT3079667T (lt) | Farmacinės vaisto formos | |
| DK3047028T5 (da) | Fermenteringsfremgangsmåde | |
| HUE051592T2 (hu) | Kezelési módszer | |
| PL3083648T3 (pl) | Sposób farmaceutyczny i półprodukty | |
| HRP20171888T1 (hr) | Farmaceutski pripravci | |
| DK2972363T3 (da) | Immunpotenserende nanobærerlægemiddel | |
| FR3003469B1 (fr) | Autoinjecteur | |
| FR3003470B1 (fr) | Autoinjecteur | |
| FI20130090L (fi) | Prosessijärjestelmä ja -menetelmä |